ENGN CIK: 1980845

enGene Therapeutics Inc.

  • Canada
  • Healthcare
  • Biotech
Metrics score locked — part of Premium
FY22
FY23
FY24
FY25
FY22 – FY25
(positive)
Change from FY22 to FY25
millions USD
FY22:
−17.6
FY23:
−24.7
FY24:
−48.3
FY25:
−99.2
Change from FY22 to FY25
millions USD
FY22:
−0.15
FY23:
−0.32
FY24:
−126
FY25:
−25.1
Change from FY22 to FY25
millions USD
FY22:
28.0
FY23:
86.1
FY24:
266
FY25:
1.52
millions USD
FY22:
9.42
FY23:
61.1
FY24:
91.5
FY25:
−123
(positive)
Change from FY22 to FY25
millions USD
FY22:
−17.7
FY23:
−25.1
FY24:
−49.2
FY25:
−101

All amounts in millions USD Data source:SEC EDGAR